0001567619-21-002413.txt : 20210208
0001567619-21-002413.hdr.sgml : 20210208
20210208125919
ACCESSION NUMBER: 0001567619-21-002413
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210204
FILED AS OF DATE: 20210208
DATE AS OF CHANGE: 20210208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Neylan John F.
CENTRAL INDEX KEY: 0001640447
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39990
FILM NUMBER: 21600447
MAIL ADDRESS:
STREET 1: 750 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Angion Biomedica Corp.
CENTRAL INDEX KEY: 0001601485
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113430072
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 51 CHARLES LINDBERGH BOULEVARD
CITY: UNIONDALE
STATE: NY
ZIP: 11553
BUSINESS PHONE: (415) 655-4899
MAIL ADDRESS:
STREET 1: 51 CHARLES LINDBERGH BOULEVARD
CITY: UNIONDALE
STATE: NY
ZIP: 11553
4
1
doc1.xml
FORM 4
X0306
4
2021-02-04
0
0001601485
Angion Biomedica Corp.
ANGN
0001640447
Neylan John F.
C/O ANGION BIOMEDICA CORP.
51 CHARLES LINDBERGH BLVD.
UNIONDALE
NY
11553
0
1
0
0
See Remarks
Stock Option (Right to Buy)
16
2021-02-04
4
A
0
70012
0.00
A
2031-02-03
Common Stock
70012
70012
D
1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from February 4, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Senior Vice President and Chief Medical Officer
/s/ Jennifer J. Rhodes, as attorney-in fact for John F. Neylan
2021-02-08